売上構成比はsix months ended June 26, 2026の推計であり、提出された報告書の数字ではありません。
Cytiva bioprocessing products
Filters, resins, liquids, single-use equipment, and services that drugmakers use to develop and manufacture biological medicines.
Pall filtration products
Filters and related equipment that remove contaminants from liquids and gases used in medicine, research, food production, electronics manufacturing, and other industries.
Biacore 8S
A Cytiva instrument that lets researchers test how potential drug molecules interact with their targets.
SCIEX mass spectrometers
Instruments that identify and measure molecules in samples, used in drug research, clinical testing, and food and environmental testing.
Beckman Coulter clinical testing systems
Laboratory instruments, tests, and software that analyze blood and other body samples to help diagnose and monitor health conditions.
Cepheid GeneXpert tests
Systems and tests that detect genetic material from organisms or diseases, including tests used in hospitals and other care settings.
Danaher owns more than 15 operating companies grouped into biotechnology, life sciences, and diagnostics. Their products help researchers study cells and other biological material, help drugmakers make biological medicines, and help healthcare workers test samples and monitor patients. Many products are used up or replaced regularly, so customers buy supplies as well as instruments and services.
Danaher Corp. 自身が米国証券取引委員会（SEC）に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
$232.95+0.3%11月13日 終値
2026年9月25日までの数値（2026年10月21日提出の10-Qより）
Danaher sells instruments, supplies, and services used in biological research, drug manufacturing, and medical testing.
The themes Danaher is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
TMOThermo Fisher Scientific Inc.$259.4BA+
IDXXIdexx Laboratories Inc.$55.5BA+
IQVIQVIA Holdings Inc.$43.7BA
ILMNIllumina, Inc.$31.3BA+
LHLabcorp Holdings Inc.$30.1BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
GEHCGE Healthcare Technologies Inc.2026年10月28日CAGraded C, now A
BIIBBiogen Inc.2026年10月28日BAGraded B, now AGrade B+
株価の下の帯は各日付時点の評価で、その時点までに公開された書類だけで算出しています。
Danaher Corp. の評価履歴 40 四半期のうち 2 四半期を表示しています。 残る 38 四半期は 2017年2月 まで遡ります。
